https://doi.org/10.1016/s0140-6736(21)00432-3
K
Katie Ewer
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
181
Papers
23.0K
Citations
56
h-index
106
i10-index
Katie Ewer is an academic researcher from University of Oxford. The author has contributed to research in topics: Malaria Research and Control & Mosquito-borne diseases and control & SARS-CoV-2 and COVID-19 Research. The author has an h-index of 56, co-authored 154 publications.
ORCID: 0000-0001-9827-9836Papers by this author
worksSingle-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
2021 · The Lancet · 1,200 citations
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial
2021 · The Lancet · 649 citations
https://doi.org/10.1016/s0140-6736(21)00628-0
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial
2021 · The Lancet HIV · 255 citations
https://doi.org/10.1016/s2352-3018(21)00103-x
Comparative assessment of vaccine vectors encoding ten malaria antigens identifies two protective liver-stage candidates
2015 · Scientific Reports · 55 citations
https://doi.org/10.1038/srep11820
A Phase Ia Study to Assess the Safety and Immunogenicity of New Malaria Vaccine Candidates ChAd63 CS Administered Alone and with MVA CS
2014 · PLoS ONE · 51 citations
https://doi.org/10.1371/journal.pone.0115161
Assessment of novel vaccination regimens using viral vectored liver stage malaria vaccines encoding ME-TRAP
2018 · Scientific Reports · 43 citations
https://doi.org/10.1038/s41598-018-21630-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat